Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5191149
Max Phase: Preclinical
Molecular Formula: C36H39N3O4
Molecular Weight: 577.73
Associated Items:
ID: ALA5191149
Max Phase: Preclinical
Molecular Formula: C36H39N3O4
Molecular Weight: 577.73
Associated Items:
Canonical SMILES: Cc1c(COc2ccc(CNCCCCCCC(=O)NO)c(OCc3cccc(C#N)c3)c2)cccc1-c1ccccc1
Standard InChI: InChI=1S/C36H39N3O4/c1-27-32(15-10-16-34(27)30-13-5-4-6-14-30)26-42-33-19-18-31(24-38-20-8-3-2-7-17-36(40)39-41)35(22-33)43-25-29-12-9-11-28(21-29)23-37/h4-6,9-16,18-19,21-22,38,41H,2-3,7-8,17,20,24-26H2,1H3,(H,39,40)
Standard InChI Key: MWSWGNOJFLALFM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 577.73 | Molecular Weight (Monoisotopic): 577.2941 | AlogP: 7.24 | #Rotatable Bonds: 16 |
Polar Surface Area: 103.61 | Molecular Species: BASE | HBA: 6 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.63 | CX Basic pKa: 9.23 | CX LogP: 6.62 | CX LogD: 5.67 |
Aromatic Rings: 4 | Heavy Atoms: 43 | QED Weighted: 0.07 | Np Likeness Score: -0.72 |
1. Xu X, Zhang D, Zhao T, Wang M, Li Y, Du Q, Kou J, Li Z, Bian J.. (2022) Novel biphenyl-based scaffold as potent and selective histone deacetylase 6 (HDAC6) inhibitors: Identification, development and pharmacological evaluation., 233 [PMID:35245830] [10.1016/j.ejmech.2022.114228] |
Source(1):